Top Story


Home >> Marketing >> Article

Crocin Quick gives GSK a headache

Font Size   16
Crocin Quick gives GSK a headache

Gujarat's FDCA seeks a nationwide ban on Crocin Quick.

Crocin Quick has given GSK Consumer Healthcare a headache. The newly launched crocin variant has been prohibited in Gujarat and the Gujarat Food & Drug Control Administrator (FDCA) has written to the regulator, Drug Controller-General of India (DCGI), to impose a nationwide ban.

Gujarat FDCA Commissioner Subhodh P Adeshara told Business Standard that the Crocin variant, called Crocin Quick, had been prohibited in the state on the grounds that the product did not meet the accepted standards of drug dissolution specified for paracetamol and it had a prohibitive colouring agent, Titanium Dioxide.

“Since the FDCA does not have the power to ban the product, we have prohibited it in our territory and has informed DCGI and also the Drug Controller of Karnataka, where the drug is manufactured,” he said.

He added that the prohibition made the company withdraw the product from the market. The state did not allow the product to reach the market place, Adeshara added.

He also said the company could not give a satisfactory explanation on its claims such as quick dissolution and colour additives. “Since the Crocin Quick formulation is outside existing pharmacopoeial standards, it should be considered as a new product and needs clearance from the DCGI. But the company did not do that,” he added.

GSK Consumer Healthcare managing director Nick Massey was not available for comments.

When contacted, Leanne Cutts, vice-president (marketing) of the company, said, “GSK applied to DCGI for approval of this formulation and after obtaining this clearance, as per the process, GSK applied to the Drugs Controller, Karnataka, and received the licence for manufacture and marketing of this formulations.”

The drugs controller, Karnataka, has also replied to the FDA commissioner, Gujarat, on his queries and reafformed that the licence for the formulation had been granted on the basis of DCGI's clearance.

Titatmium dioxide is an approved colourant for any coated tablet. This is patent and proprietary medicine, and had been cleared by DCGI as a coated paracetamol tablet.

GSK Consumer Healthcare is a 100 per cent subsidiary of GSK Asia. The company is focussing on the over the counter healthcare and nutritional products in the country.

Crocin 500 is the flagship OTC brand of the GSK Consumer Healthcare. The company has recently launched two more variant of this brands -Crocin Pain relief and Crocin Quick .

The company had withdrawn another variant of Crocin, Crocin 1000, a couple of years ago due to 'strategic reasons.


Vijay Mansukhani, speaks to exchange4media about the resurgence of Onida, the scope of growth of consumer electronics market in India and the reasons why Indian consumer electronics brands don’t compete on a global scale

Projjol Banerjea opens up about hiring Anne Macdonald and GroupM's Rob Norman, and the brand's new identity

Meera Iyer tells exchange4media that in FY 2016/17, bigbasket clocked a revenue of Rs 1,400 crore. The online supermarket currently stands at 70,000 orders a day, with operations in 25 cities.

CMO, Kashyap Vadapalli on the start-up’s marketing play, why it has decided to stay away from IPL and response to its furniture rental apps

Meanwhile Radio City and Radio Mirchi ruled Bangalore and Kolkata respectively

Pankaj Belwariar, who recently resigned from the post of Vice President Marketing at Sakal Media Group, has now joined Rajasthan Patrika as the Head of Marketing in North and East region.

A look at Vivo’s ad campaign with their all-new brand ambassador Aamir Khan, which has fetched them a whopping 21 million views on YouTube